| 刘 悦,滕 熠,郑渊杰,等.GLOBOCAN 2024全球癌症统计数据解读[J].中国肿瘤,2026,35(9):661-669. |
| GLOBOCAN 2024全球癌症统计数据解读 |
| Interpretation of the Global Cancer Statistics of GLOBOCAN 2024 |
| 投稿时间：2026-08-30 |
| DOI：10.11735/j.issn.1004-0242.2026.09.A001 |
|
 |
| 中文关键词: GLOBOCAN 2024 癌症 发病 死亡 疾病负担 |
| 英文关键词:GLOBOCAN 2024 cancer incidence mortality disease burden |
| 基金项目:国家科技重大专项（2024ZD0520000，2024ZD0520005）；中国医学科学院医学与健康科技创新工程项目（2025-I2M-KJ-007） |
|
| 摘要点击次数: 52 |
| 全文下载次数: 13 |
| 中文摘要: |
| 摘 要：［目的］ 基于GLOBOCAN 2024数据，解读全球癌症负担现状、性别分布特征、地区差异以及未来负担变化。［方法］ 资料来源于国际癌症研究署（International Agency for Research on Cancer，IARC）发布的GLOBOCAN 2024数据，包括2024年全球主要癌种发病和死亡情况，以及2050年癌症负担的预测。［结果］ 2024年全球新发癌症2 063.6万例，死亡976.3万例，年龄标准化发病率（age-standardized incidence rate，ASIR）和年龄标准化死亡率（age-standardized mortality rate，ASMR）分别为194.9/10万和87.8/10万。肺癌仍为全球发病和死亡负担最重的癌种，分别占全部新发病例和死亡病例的12.8%和19.1%。男性整体癌症负担高于女性，肺癌、前列腺癌、结直肠癌构成男性主要癌症发病负担；女性癌症发病和死亡负担以乳腺癌、肺癌和结直肠癌为主。地区间癌症负担差异明显，欧美及大洋洲等发达地区癌症发病水平普遍较高，非洲和部分亚洲地区发病水平相对较低但死亡负担仍较重。2050年全球癌症疾病负担预计将进一步增加，癌症新发病例增至3 439.5万例，死亡增至1 749.2万例。［结论］ 2024年全球癌症负担较为严峻，至2050年癌症发病及死亡人数将持续上升。肺癌、乳腺癌、结直肠癌、肝癌和胃癌仍是全球癌症防控重点，亟需结合不同地区和人群特点深入实施和推广癌症防治工作。 |
| 英文摘要: |
| Abstract：［Purpose］ To describe the current global cancer burden， sex differences， regional variations， and future trends， based on the data from GLOBOCAN 2024. ［Methods］ The data come from the GLOBOCAN 2024 database published by the International Agency for Research on Cancer. We analyzed the incidence and mortality rates of major cancers worldwide in 2024， and used predicted data for 2050 to forecast future trends. ［Results］ In 2024， there were 20.636 million new cancer cases and 9.763 million cancer-related deaths worldwide. The age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) stood at 194.9/105 and 87.8/105 population， respectively. Lung cancer remained the cancer with the heaviest global incidence and mortality burden， accounting for 12.8% of all new cancer cases and 19.1% of all cancer deaths. Overall cancer burden was higher in men than that in women. Lung cancer， prostate cancer and colo-rectal cancer were the major contributors to cancer incidence among men. For women， breast cancer， lung cancer and colorectal cancer were the main contributors to both incidence and mortality burden. Substantial regional disparities in cancer burden were observed. Developed regions including Europe， the Americas and Oceania generally presented high cancer incidence levels. By contrast， regions in Africa and parts of Asia had relatively low incidence levels yet still bore a heavy mortality burden. The global cancer burden is projected to increase further by 2050， with new cases rising to 34.395 million and cancer-related deaths reaching 17.492 million. ［Conclusion］ In 2024， the global cancer burden was severe. Till 2050， the number of cases and deaths due to cancer will continue to increase. Lung cancer， breast cancer， colorectal cancer， liver cancer， and stomach cancer remain the priorities for global cancer prevention and control. It is necessary to implement and promote cancer prevention and control measures more effectively， taking into account the characteristics of different regions and populations. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |